Dow Up 0.19% Nasdaq Up 0.56%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
192.55 Up 0.59(0.31%) 4:00PM EST
|After Hours : 192.55 0.00 (0.00%) 5:32PM EST
Prev Close:191.96
Open:190.90
Bid:192.58 x 200
Ask:193.99 x 100
1y Target Est:207.20
Beta:1.4
Earnings Date:Jan 28 - Feb 2 (Est.)
Day's Range:189.45 - 193.23
52wk Range:119.69 - 197.64
Volume:554,249
Avg Vol (3m):1,122,650
Market Cap:38.18B
P/E (ttm):80.10
EPS (ttm):2.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 0.31%38.18B
AMGNUp 0.02%123.75B
BAXDown 0.65%39.02B

Key Statistics

Forward P/E (1 yr):32.80
P/S (ttm):18.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.20
Quarterly EPS Est (Dec-14) :1.29
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback